Kura Oncology partners with Kyowa Kirin for blood cancer therapy – 11/20/2024 at 11:36 p.m.
(Automated translation by Reuters, please see disclaimer (Added details on the medicine and the partnership in paragraphs 2 to 6) Kura Oncology KURA.O said on Wednesday it would collaborate with Japan’s Kyowa Kirin 4151.T to develop and commercialize ziftomenib, a blood cancer treatment. Kuradi will lead the development of the drug, which is currently being … Read more